Development and validation of method for analysis of favipiravir and remdesivir in volumetric absorptive microsampling with ultra high-performance liquid chromatography–tandem mass spectrophotometry

Development and validation of method for analysis of favipiravir and remdesivir in volumetric absorptive microsampling with ultra high-performance liquid chromatography–tandem mass spectrophotometry

Favipiravir and remdesivir are drugs to treat COVID-19. This study aims to find an optimum and validated method for simultaneous analysis of favipiravir and remdesivir in Volumetric Absorptive Microsampling (VAMS) by Ultra High-Performance Liquid Chromatography–Tandem Mass Spectrophotometry. The use...

Full description

Bibliographic Details
Main Authors:	Yahdiana Harahap, Roesytas Fitria Noer, Timbul Partogi H. Simorangkir
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Medicine
Subjects:	favipiravir remdesivir VAMS LC-MS/MS COVID-19 acyclovir
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1022605/full

Similar Items

Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry
by: Yahdiana Harahap, et al.
Published: (2024-04-01)

Determination of warfarin in volumetric absorptive microsampling by liquid chromatography-tandem mass spectrometry
by: Yahdiana Harahap, et al.
Published: (2024-07-01)

Development and validation of a UPLC-MS/MS method with volumetric absorptive microsampling to quantitate cyclophosphamide and 4-hydroxycyclophosphamide
by: Yahdiana Harahap, et al.
Published: (2022-08-01)

Mucocutaneous adverse effects of remdesivir and favipiravir in patients with Covid-19 infection: A systematic review
by: Pradeep Balasubramanian, et al.
Published: (2022-01-01)

Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
by: Mohamed S. Imam, et al.
Published: (2023-07-01)

Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta
by: Nova Satriyani, et al.
Published: (2023-01-01)

Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters
by: Megan Neary, et al.
Published: (2024-11-01)

Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
by: Hegazy Sahar K., et al.
Published: (2023-08-01)

Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers
by: Michele Protti, et al.
Published: (2022-09-01)

Effects of the RNA-Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers—An MD Study
by: Mauro Bringas, et al.
Published: (2022-09-01)

Perbandingan Luaran Klinis Favipiravir dan Remdesivir pada Pasien Covid-19 Derajat Sedang di RS Akademik UGM Yogyakarta
by: Hadiatussalamah Hadiatussalamah, et al.
Published: (2023-09-01)

Remdesivir versus Favipiravir in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia: A Propensity Score-Matched Retrospective Cohort Study
by: Chavalertsakul K, et al.
Published: (2024-05-01)

A Volumetric Absorptive Microsampling UPLC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Mycophenolic Acid and Creatinine in Whole Blood of Renal Transplant Recipients
by: Xueqiao Wang, et al.
Published: (2022-11-01)

FAVIPIRAVIR AND DEXAMETHASONE IN MANAGEMENT OF SARS-COV2 INFECTION
by: M. Latief, et al.
Published: (2021-05-01)

Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics
by: Camilla Marasca, et al.
Published: (2021-01-01)

Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
by: Afnan S. Batubara, et al.
Published: (2023-06-01)

Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma
by: Mohammad Hailat, et al.
Published: (2021-06-01)

Volumetric Absorptive Microsampling as an Alternative Tool for Biomonitoring of Multi-Mycotoxin Exposure in Resource-Limited Areas
by: Arnau Vidal, et al.
Published: (2021-05-01)

Analysis of N7-(2-carbamoyl-2-hydroxyethyl)guanine in dried blood spot after food exposure by Ultra High Performance Liquid Chromatography–Tandem Mass Spectrometry
by: Yahdiana Harahap, et al.
Published: (2022-11-01)

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-09-01)

The rs11385942 and rs657152 variants are not associated with COVID-19 severity and outcomes in patients treated with favipiravir and remdesivir
by: Sh. P. Abdullaev, et al.
Published: (2024-01-01)

Structural Elucidation of Alkali Degradation Impurities of Favipiravir from the Oral Suspension: UPLC-TQ-ESI-MS/MS and NMR
by: Ravi Patel, et al.
Published: (2022-08-01)

Volumetric Absorptive Microsampling in the Analysis of Endogenous Metabolites
by: Daniel Marques de Sá e Silva, et al.
Published: (2023-09-01)

Development and validation of UPLC-MS/MS method for 5-Fluorouracil quantification in dried blood spot
by: Yahdiana Harahap, et al.
Published: (2024-05-01)

Ultra high-performance liquid chromatography tandem mass spectrometry: Development and validation of an analytical method for N2-Ethyl-2’-deoxyguanosine in dried blood spot
by: Dimas Prayuda, et al.
Published: (2024-10-01)

In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
by: Siva Swapna Kasarla, et al.
Published: (2022-10-01)

Use of Favipiravir in Covid-19 Patients: A Narrative Review
by: Vitarani Dwi Ananda Ningrum, et al.
Published: (2024-05-01)

Development and Validation of the Quantification Method for Hydroxychloroquine in Volumetric Absorptive Microsampling (VAMS) Using High-Performance Liquid Chromatography-Photodiode Array
by: Yahdiana Harahap, et al.
Published: (2021-01-01)

Pharmacokinetic analysis and tissue distribution of Vam3 in the rat by a validated LC-MS/MS method
by: Ruixia Zhang, et al.
Published: (2015-05-01)

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-02-01)

Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique
by: Michela Palmisani, et al.
Published: (2023-07-01)

Hematological Malignancy Patients, COVID-19, and Favipiravir
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-12-01)

The Evolving Role of Microsampling in Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Diseases
by: Panagiotis-Dimitrios Mingas, et al.
Published: (2021-03-01)

Tricyclic Derivative of Acyclovir and Its Esters in Relation to the Esters of Acyclovir Enzymatic Stability: Enzymatic Stability Study
by: Izabela Muszalska-Kolos, et al.
Published: (2020-05-01)

Validation of a UPLC-MS/MS Method for Multi-Matrix Biomonitoring of <i>Alternaria</i> Toxins in Humans
by: Lia Visintin, et al.
Published: (2024-06-01)

Fabric phase sorptive extraction-gas chromatography-mass spectrometry for the determination of favipiravir in biological and forensic samples
by: Rajeev Jain, et al.
Published: (2023-05-01)

Occlusion-based model weighting for volumetric additive manufacturing around inserts
by: Ahmad Bagheri, et al.
Published: (2024-12-01)

Evaluation of the effect of favipiravir on patients with COVID-19
by: Alireza Kamali, et al.
Published: (2023-02-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
by: A. S. Zmitrukevich, et al.
Published: (2024-01-01)

Perspective: repurposed Drugs for COVID-19
by: Kesara Na-Bangchang, et al.
Published: (2022-08-01)